HKU Team Finds Way To Treat Covid With Ulcer Drug
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1554222_1_20201012174849.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1554222-20201012.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1554222-20201012.htm', 'DCS.dcsqry', '' ); } } }); }); });
2020-10-12 HKT 12:48
Share this story
Researchers at the University of Hong Kong said on Monday that they have found that a way to tackle the novel coronavirus with a drug that is commonly used to treat stomach ulcers.
They said experiments in the laboratory showed that the drug, ranitidine bismuth citrate (RBC), which contains a metal called bismuth, can be used to reduce viral loads in coronavirus-infected cells by over 1,000-fold.
Dr Runming Wang from the university’s Department of Chemistry said the drug is also cheaper and safer than Remdesivir, which is currently used to treat Covid-19.
He said the drug works by targeting a protein in the virus and preventing the virus from replicating.
“As the process of developing an effective vaccine is still ongoing, another approach for preventing and treatment of the disease is to identify anti-Covid-19 agents from existing drugs to repurpose their uses,” he said.
Wang said the drug can be stored at room temperature and without any special requirements.
The team said it had applied for a patent in the US.
HKMA Warns Of Fake Stablecoins As Licensed Issuers Have Yet To Launch Tokens
The Hong Kong Monetary Authority (HKMA) has warned the public about fake stablecoins in Hong Kong, specifically flaggin... Read more
Tazapay Secures Money Service Operator License In Hong Kong
Singapore-based cross-border payments company Tazapay has secured a Money Service Operator (MSO) license in Hong Kong. ... Read more
Livi Bank Posts First Full-Year Profit In 2025 As Loans Rise 49%
Hong Kong digital bank livi bank reported a full-year profit of HK$21 million for 2025. For the year, total operating i... Read more
FWD Group Reports US$720M In New Business Sales As Expansion Continues
FWD Group reported a 4% year-on-year increase in new business sales to US$720 million for the first quarter of 2026, dr... Read more
WeLab Bank 2025 Revenue Hits HK$942M After Securing First-Half Profitability
WeLab Bank achieved profitability in the first half of 2025 and reported a 35% year-on-year revenue increase to HK$942 ... Read more
Ripple And Kbank Roll Out Institutional Digital Asset Wallet In South Korea
Ripple has partnered with Kbank to deploy an institutional digital asset wallet in Korea, equipping the internet bank w... Read more